US$ 24.71
glp-1 drugs compounded Medications for Seniors | Weight Compounded GLP-1 | Joi +
Description
Accompanying the increase in use of these drugs has been a surge in individuals seeking guidance regarding their side effects, as well as accidental overdoses

doi: 10.1111/exd.13442 [DOI] [PubMed] [Google Scholar] 178

Among patients who previously used a GLP-1-based medication, most switched from injectable anti-obesity medications (AOM), including injectable AOM semaglutide (sold as Wegovy) and AOM tirzepatide (sold as Zepbound)

This interaction extends beyond glucose regulation and may provide novel therapeutic targets for metabolic and inflammatory diseases

Clinical Interpretation For the vast majority of patients, GLP1 RAs remain safe from a pancreatitis perspective

Metabolism 62 (3), 347351
